saw103

Scott A.. Waldman, MD, PhD

Contact Dr. Waldman

132 South 10th Street
Suite 1170
Philadelphia, PA 19107

(215) 955-6086
(215) fax

Most Recent Peer-reviewed Publications

  1. Clinical Pharmacology & Therapeutics: Past, Present, and Future
  2. EXECUTIVE INTERVIEW - Viral gene: Protein-targeting cancer vaccine could boost survival rates
  3. Preclinical Evaluation of a Replication-Deficient Recombinant Adenovirus Serotype 5 Vaccine Expressing Guanylate Cyclase C and the PADRE T-helper Epitope
  4. A survey of physician receptivity to molecular diagnostic testing and readiness to act on results for early-stage colon cancer patients
  5. Guanylyl cyclase C signaling axis and colon cancer prevention
  6. Guanylyl cyclase C hormone axis at the intersection of obesity and colorectal cancer
  7. Targeting guanylate cyclase C in colorectal cancer: Where are we now?
  8. GUCY2C ligand replacement to prevent colorectal cancer
  9. Big data transforms discoveryutilization therapeutics continuum
  10. Obesity-induced colorectal cancer is driven by caloric silencing of the guanylin-GUCY2C paracrine signaling axis
  11. Bioinnovation Enterprise: An Engine Driving Breakthrough Therapies
  12. Intestinal enteroids model guanylate cyclase C-dependent secretion induced by heat-stable enterotoxins
  13. Guanylyl cyclase C as a biomarker
  14. CD19-targeted nanodelivery of doxorubicin enhances therapeutic efficacy in B-cell acute lymphoblastic leukemia
  15. Companion diagnostics at the intersection of personalized medicine and healthcare delivery
  16. Clinical pharmacology & therapeutics: The next five years
  17. A novel CDX2 isoform regulates alternative splicing
  18. Tumor radiation therapy creates therapeutic vaccine responses to the colorectal cancer antigen GUCY2C
  19. Managing the innovation supply chain to maximize personalized medicine
  20. Molecular insights provide the critical path to disease mitigation